CLSI eNews - 2 June 2008 (Plain Text Version)

Return to Graphical Version | Search back issues | Print all articles

In this issue:
Note on printing single articles: Each selected individual article will appear at the bottom of this screen...please scroll down to view/print the selected article.

News
President's Message
Volunteer Focus
Lab Guidelines & Standards
CLSI Catalog Supplement
Press Releases
Standards Status
Vote and Deadlines
Recently Approved Documents
Call for Nominations
Events and Exhibits
Upcoming Events
Teleconferences
Forums Training
Upcoming Presentations
CLSI Meetings Calendar
Participate in CLSI
Volunteer
Career Opportunities
New and Sustaining Members
Update Your Subscription

Recently Approved Documents

Verification of Comparability of Patient Results Within One Health Care System (C54-A)
One-Stage Prothrombin Time (PT) Test and Activated Partial Thromboplastin Time (APTT) Test (H47-A2)
Specification for Low-Level Protocol to Transfer Messages Between Clinical Laboratory Instruments and Computer Systems (LIS01-A2)
Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts (M27-A3)
Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts (M27-S3)
Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi (M38-A2)
Laboratory Detection and Identification of Mycobacteria (M48-A)
Interpretive Criteria for Microorganism Identification of Bacteria and Fungi by DNA Target Sequencing (MM18-A)
Implementation Guide of POCT1 for Health Care Providers (POCT02-A)

C54-A—Verification of Comparability of Patient Results Within One Health Care System; Approved Guideline
This document provides guidance on how to verify comparability of quantitative laboratory results for individual patients within a health care system.
Purchase here.

H47-A2—One-Stage Prothrombin Time (PT) Test and Activated Partial Thromboplastin Time (APTT) Test; Approved Guideline—Second Edition
This document provides guidelines for performing the PT and APTT tests in the clinical laboratory, for reporting results, and for identifying sources of error.
Purchase here.

M48-A—Laboratory Detection and Identification of Mycobacteria; Approved Guideline
This document provides guidance to clinical mycobacteriology laboratories on the most optimum approach for the diagnosis of mycobacterial infections.
Purchase here.

POCT02-A—Implementation Guide of POCT1 for Health Care Providers; Approved Guideline
This document identifies and describes the particular features that a POCT1-compliant device should ideally have. These features are divided into obligatory and desirable categories. Key terms are identified and the most frequent use cases are presented. The guideline thus gives the health care provider or end user a practical basis for establishing a list of features or questions to be addressed by the vendor of a compliant device.
Purchase here.

Second Notice

M27-A3—Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard—Third Edition
This standard addresses the selection and preparation of antifungal agents; implementation and interpretation of test procedures; and quality control requirements for susceptibility testing of yeasts that cause invasive fungal infections.
Purchase here.

M27-S3—Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Third Informational Supplement
This supplemental table provides updated QC ranges and interpretive criteria for broth microdilution testing for CLSI document M27-A3—Reference Methods for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Two charts are laminated for easy posting.
Purchase here.

M38-A2—Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; Approved Standard—Second Edition
This document addresses the selection of antifungal agents; preparation of antifungal stock solutions and dilutions for testing; implementation and interpretation of test procedures; and quality control requirements for susceptibility testing of filamentous fungi (moulds) that cause invasive fungal infections.
Purchase here.

LIS01-A2—Specification for Low-Level Protocol to Transfer Messages Between Clinical Laboratory Instruments and Computer Systems; Approved Standard—Second Edition
This document describes the electronic transmission of digital information between clinical laboratory instruments (those that measure one or more parameters from one or multiple samples) and computer systems (those that are configured to accept instrument results for further processing, storage, reporting, or manipulation).
Purchase here.

MM18-A—Interpretive Criteria for Microorganism Identification of Bacteria and Fungi by DNA Target Sequencing; Approved Guideline
Sequencing of DNA targets of cultured isolates provides a quantitative metric within which to perceive microbial diversity, and can serve as the basis to identify microorganisms. This document is an effort to catalyze the entry of molecular microbiology into clinical usage by establishing interpretive criteria for microorganism identification.
Purchase here.